RHIZEN PHARMACEUTICALS AG

City:

Basel

Country:

Switzerland

Published Applications:

Last publication date:

2023-06-01

Patent Grants:

Last grant date:

2025-09-30

Top Inventors for applications by RHIZEN PHARMACEUTICALS AG

These are the the leading inventors for applications assigned to RHIZEN PHARMACEUTICALS AG:

Srikant Viswanadha 3 Hyderabad, India
Govindarajulu BABU 3 Hyderabad, India
Swaroop K. Vakkalanka 3 La Chaux-de-Fonds, Switzerland
Prashant K. BHAVAR 2 Hyderabad, India

Babu GOVINDARAJULU 1 Hyderabad, India
SRIDHAR VEERARAGHAVAN 1 Hyderabad, India
Swaroop Kumar Venkata Satya Vakkalanka 1 La Chaux de Fonds, Switzerland
Swaroop K. Vakkalanka 1 Lu Chaux-de-Fonds, Switzerland

Meyyappan MUTHUPPALANIAPPAN 1 Hyderabad, India
Prashant Kashinath Bhavar 1 Hyderabad, India
Swaroop Kumar Venkata Satya VAKKALANKA 1 Basel, Switzerland
Jayaraman V. Raman 1 Vadodara, India

Recent patent applications by RHIZEN PHARMACEUTICALS AG

RHIZEN PHARMACEUTICALS AG based in Basel, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-06-01 ✅ Patent 12,428,422 granted on 2025-09-30

US20230167116A1

Chemistry; metallurgy

PURINE DERIVATIVES AS SIK-3 INHIBITORS

#2 | 2021-02-04 ✅ Patent 11,466,006 granted on 2022-10-11

US20210032248A1

Chemistry; metallurgy

Dual selective PI3 delta and gamma kinase inhibitors

#3 | 2020-07-30 ✅ Patent 11,858,907 granted on 2024-01-02

US20200239427A1

Chemistry; metallurgy

Kinase modulators

#4 | 2019-02-07 ✅ Patent 11,478,481 granted on 2022-10-25

US20190038634A1

Human necessities

Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals

#5 | 2016-07-21 ✅ Patent 11,352,359 granted on 2022-06-07

US20160207929A1

Chemistry; metallurgy

PI3K protein kinase inhibitors

Also check out RHIZEN PHARMACEUTICALS AG's (Basel, Switzerland) applicant profile with 3 patent applications submitted.

AssigneeID:

349006 ⎘